Key result
Tisdale Score correctly flags ~90% of QTc prolongation cases as elevated risk despite low specificity.
Observational (n=917)
No
The Tisdale Score demonstrated high sensitivity but low specificity for predicting QTc prolongation in non-cardiac inpatients, though limited ECG availability and few events restrict the precision of these estimates.
Answers are grounded in this paper and cite their sources.
Tisdale Score showed variable sensitivity across non-cardiac wards; limited events and ECGs leave broader applicability open.
BACKGROUND: QTc prolongation is associated with an increased risk of life-threatening arrhythmias. The Tisdale Score was originally developed for risk stratification in cardiac intensive care patients. However, its applicability to other medical specialties remains insufficiently investigated. OBJECTIVE: To evaluate the prevalence of risk factors for QTc prolongation and the performance of the Tisdale Score in patients admitted to surgical-nephrological (CH/N), neurological (NEU), and psychiatric (PSY) general wards. METHODS: In this retrospective study, at least 300 adult inpatients per specialty (admission period July to December 2023) were included. For the day of admission, risk factors for QTc prolongation and administered QTc-prolonging drugs (QTcD) were recorded. Available ECGs were analyzed for QTc prolongation and sensitivity and specificity of the Tisdale Score were calculated. RESULTS: Of 301 CH/N, 306 NEU, and 310 PSY patients, 85.7%, 78.4%, and 87.4% received at least one QTcD, respectively. ECGs were available for 13.6% (CH/N), 17.0% (NEU), and 76.1% (PSY) of patients. QTc prolongation was detected in 3 (7.3%), 5 (9.6%), and 2 (0.9%) patients, respectively. All but one patient with QTc prolongation had a moderate or high Tisdale Score. Sensitivity and specificity were 66.7%/39.5% (CH/N), 100%/53.2% (NEU), and 100%/66.7% (PSY). CONCLUSION: In this retrospective study, most patients with QTc prolongation had a moderate or high Tisdale Score. However, the low number of QTc prolongations and limited ECG availability restrict the precision of performance estimates. Larger studies with more comprehensive ECG monitoring are required to determine the usability of the Tisdale Score for risk stratification in non-cardiac patients.
No takes yet. Share an insight, caveat, or question.
Görgen et al. (2026) conducted an observational in Risk for QTc prolongation (n=917). Tisdale Score risk factors and QTc-prolonging drugs vs. Low Tisdale Score risk was evaluated on QTc prolongation (≥ 500 ms or ΔQTc ≥ 60 ms). Among 917 non-cardiac inpatients, 9 of 10 patients with documented QTc prolongation were correctly classified as moderate or high risk by the Tisdale Score, demonstrating high sensitivity but low specificity.
Synapse has enriched 10 related papers. Consider them for comparative context: